Category: Hematological Disorders

Home / Established Year

Guideline for the treatment of mixed phenotype acute leukemia

A study conducted at the Los Angeles Children ’s Hospital is providing the best treatment for a rare invasive leukemia called mixed phenotype acute leukemia (MPAL).This study (a 20-year quantitative synthesis of the scientific l..

Treatment for advanced lymphoma

Yesterday, the US FDA announced the approval of Seattle Genetics' antibody-drug conjugate Adcetris (brentuximab vedotin) in combination with chemotherapy for patients with previously treated stage III or IV classic Hodgkin's lymph..

This anticancer drug still benefits after 5 years of treatment for leukemia

According to the results of a 5-year follow-up of the key PACE trial published in the Journal of Hematology, panatinib (Ponatinib, Iclusig) has maintained long-lasting in severely treated patients with chronic phase chronic myeloi..

Drugs for lymphoma leukemia to treat brain tumors

New Cleveland Clinic research shows for the first time that FDA-approved ibrutinib (ibrutinib) for lymphoma and leukemia may also help treat the most common and deadly brain tumors, and may one day be used in patients with gliobla..

First-line bosutinib is superior to imatinib in the treatment of leukemia

Bosutinib is a Src / Abl dual tyrosine kinase inhibitor approved for the treatment of newly diagnosed chronic phase (CP) chronic myelogenous leukemia (CML), or resistant or intolerant to previous treatments CML. The study compare..

Lipid-lowering drugs are expected to assist in the treatment of leukemia

The latest research found that some statins can improve the efficacy of chemotherapy drugs used to treat blood cancer in mouse models. Statins are drugs that treat patients with reduced fat in the blood. They are commonly used to..

Can bone marrow fibrosis drugs induce lymphoma?

Bone marrow fibrosis is a rare chronic disease of bone marrow hematopoietic cells. They benefit from JAK2 inhibitor drugs: symptom relief, prolonged survival, and improved quality of life. However, two or three years after starti..

Venetoclax therapy for leukemia

On June 8 , the US FDA approved Venetoclax ( VENCLEXTA , AbbVie Inc. and Genentech Inc. ) for patients with chronic lymphocytic leukemia ( CLL ) or small lymphocytic lymphoma ( SLL ), with or without 17p deletion, at least Receive..

Lymphoma: Pembrolizumab treatment approved

On June 12-13, FDA approved two new indications for K drug, just the day before the K drug was approved for the treatment of cervical cancer. One day later, the US FDA approved pembrolizumab (Keytruda, pembrolizumab) for the trea..

Researchers discover a new mechanism of lymphoma resistance

In the United States, more than 70,000 people are diagnosed with non-Hodgkin's lymphoma each year, which is caused by excessive proliferation of immune cells in the body's lymph nodes. The most common is diffuse large B-cell lymp..

Newer Older
Start chat
Need help with cancer treatment?
Scan the code
Hello,
Welcome to CancerFax !

CancerFax is the most trusted international patient facilitator working with top cancer hospital's in the world like MD Anderson, Dana Farber, Asan, NCC Japan, Sheba, Beijing Cancer Institute and Apollo to bring you best of therapies and drugs.

Let us know what services would you like to avail?

1) Cancer treatment in the USA, Japan, Israel, India, Korea or Singapore?
2) CAR T-Cell therapy treatment
3) Cancer vaccine
4) Online video consultation
5) Proton therapy